© 2022 MJH Life Sciences™ and Neurology Live. All rights reserved.
American Epilepsy Society Annual Meeting
Untapping the Potential of Seizure Applications, Telemedicine
December 14, 2021
Jessica Fesler, MD, MEd, staff epileptologist, Cleveland Clinic, offered insight on the future of seizure apps and how if improved, they could alter the treatment of patients with epilepsy.
Shifting to a Holistic Approach to Treat Developmental Epileptic Encephalopathies
December 13, 2021
The medical director of the Epilepsy program at the University of Toronto discussed her presentation at AES 2021 regarding the need to change how clinicians view and treat patients with developmental epileptic encephalopathies.
Ganaxolone’s Potential in TSC, Need for More Drug Development: Darcy Krueger, MD, PhD
December 12, 2021
The director of the Tuberous Sclerosis Clinic at Cincinnati Children’s discussed the phase 2 open-label study of ganaxolone in TSC and whether drug development remains the top priority for these patients. [WATCH TIME: 3 minutes]
Perampanel Improves Comorbid Intellectual Disability, Effects of CBTip in PNES, Cenobamate's Impact in Surgically-Refractory Patients
December 11, 2021
Neurology News Network for the week ending December 11, 2021. [WATCH TIME: 4 minutes]
Recent Advances, Future Developments in Epilepsy Surgery: Imad Najm, MD
December 10, 2021
The director of Cleveland Clinic’s Epilepsy Center at the Cleveland Clinic Neurological Institute spoke on the latest advances with epilepsy surgery, as well as what still needs to be learned. [WATCH TIME: 5 minutes]
Live Reactions From AES 2021: Trends, Encouraging Research, and Expert Presentations
December 10, 2021
Leaders in the epilepsy space provided their thoughts on the most promising aspects, initial takeaways, and dominating conversations at the 2021 American Epilepsy Society annual meeting.
Takeaways From AES 2021: Imad Najm, MD
December 09, 2021
The director of Cleveland Clinic’s Epilepsy Center at the Cleveland Clinic Neurological Institute discussed poignant presentations from the 2021 American Epilepsy Society Annual Meeting. [WATCH TIME: 7 minutes]
Cenobamate’s Efficacy Profile in Treating Seizures: William Rosenfeld, MD
December 09, 2021
The neurologist from the Comprehensive Epilepsy Care Center for Children and Adults, in St. Louis, Missouri, discussed numerous presentations from AES 2021 that bolstered cenobamate’s known efficacy and safety profile. [WATCH TIME: 7 minutes]
Potential of Neuropalliative Care Evaluated for Patients With Drug-Resistant Epilepsy
December 08, 2021
Investigators suggest further studies to better determine is NPC had measurable benefits for patient quality of life.
Cenobamate Offers Unique Benefit for Surgically Refractory Epilepsy
December 08, 2021
Across all surgical procedures, the percentage of patients with seizure freedom for at least 12 months ranged from 20% to 35.7% for patients receiving cenobamate.